OTTAWA, May 15 /CNW Telbec/ - Liponex Inc. (TSX:LPX), a biopharmaceutical company specializing in developing products related to High Density Lipoprotein (HDL), often called “good cholesterol,” today announced its results for the three months ended March 31, 2008.
